Evidence map›Paper›PMID 35683579›Full record

ArticleJournal of clinical medicine2022

In-Hospital Antibiotic Use for COVID-19: Facts and Rationales Assessed through a Mixed-Methods Study.

Laura Elena Stoichitoiu, Larisa Pinte, Alexandr Ceasovschih, Roxana Carmen Cernat, Nicoleta Dorina Vlad, Vlad Padureanu, Laurentiu Sorodoc, Adriana Hristea, Adrian Purcarea, Camelia Badea and 1 more

Open access · goldAbstract read
In one paragraph

Article in Journal of clinical medicine, 2022. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 17 papers, 1 of them a synthesis that pooled it.

0numbers the graph read from it
0cells of the map it votes in
17citing papers in PubMed, 1 pooled it
1.6field-weighted citation impact, top 11% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

17 citing papers in PubMed, 1 synthesis or guideline pooled it, 19 citations in OpenAlex.

  1. Pooled it
  2. Article
  3. Article
  4. Article
  5. Article
  6. Review
  7. Article
  8. Article
  9. Article
  10. Article
  11. The pediatric gut bacteriome and virome in response to SARS-CoV-2 infection.Frontiers in cellular and infection microbiology · 2024
    Article
  12. Article
  13. Article
  14. Distinct Features of Vascular Diseases in COVID-19.Journal of inflammation research · 2023
    Review
  15. Article
  16. Azithromycin through the Lens of the COVID-19 Treatment.Antibiotics (Basel, Switzerland) · 2022
    Review
  17. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

11 authors at 4 institutions in 1 country.

Laura Elena StoichitoiuFaculty of Medicine, Carol Davila University of Medicine and Pharmacy, 050474 Bucharest, Romania.ORCID 0000-0002-0234-0856
Larisa PinteFaculty of Medicine, Carol Davila University of Medicine and Pharmacy, 050474 Bucharest, Romania.ORCID 0000-0002-9548-9165
Alexandr CeasovschihInternal Medicine, Grigore T. Popa University of Medicine and Pharmacy, 700111 Iasi, Romania.ORCID 0000-0002-0043-9051
Roxana Carmen CernatFaculty of Medicine, Ovidius University, 900527 Constanta, Romania.
Nicoleta Dorina VladFaculty of Medicine, Ovidius University, 900527 Constanta, Romania.ORCID 0000-0003-1230-6819
Vlad PadureanuFaculty of Medicine, University of Medicine and Pharmacy Craiova, 200349 Craiova, Romania.ORCID 0000-0001-7398-5689
Laurentiu SorodocInternal Medicine, Grigore T. Popa University of Medicine and Pharmacy, 700111 Iasi, Romania.
Adriana HristeaFaculty of Medicine, Carol Davila University of Medicine and Pharmacy, 050474 Bucharest, Romania.ORCID 0000-0002-6505-1699
Adrian PurcareaDepartment of Internal Medicine, Sacele County Hospital, 505600 Brasov, Romania.
Camelia BadeaFaculty of Medicine, Carol Davila University of Medicine and Pharmacy, 050474 Bucharest, Romania.
Cristian BaicusFaculty of Medicine, Carol Davila University of Medicine and Pharmacy, 050474 Bucharest, Romania.ORCID 0000-0002-7954-0098
Carol Davila University of Medicine and Pharmacy · ROGrigore T. Popa University of Medicine and Pharmacy · ROOvidius University · ROUniversity of Medicine and Pharmacy of Craiova · RO

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

It is well known that during the coronavirus disease 2019 (COVID-19) pandemic, antibiotics were overprescribed. However, less is known regarding the arguments that have led to this overuse. Our aim was to understand the factors associated with in-hospital antibiotic prescription for COVID-19, and the rationale behind it. We chose a convergent design for this mixed-methods study. Quantitative data was prospectively obtained from 533 adult patients admitted in six hospitals (services of internal medicine, infectious diseases and pneumology). Fifty-six percent of the patients received antibiotics. The qualitative data was obtained from interviewing 14 physicians active in the same departments in which the enrolled patients were hospitalized. Thematic analysis was used for the qualitative approach. Our study revealed that doctors based their decisions to prescribe antibiotics on a complex interplay of factors regarding the simultaneous appearance of consolidation on the chest computer tomography together with a worsening of clinical conditions suggestive of bacterial infection and/or an increase in inflammatory markers. Besides these features which might suggest bacterial co-/suprainfection, doctors also prescribed antibiotics in situations of uncertainty, in patients with severe disease, or with multiple associated comorbidities.

Indexed as

antibacterial agentsantibioticsCOVID-19mixed methodsqualitativequantitativeSARS-CoV-2

Identifiers

PMID35683579
PMCPMC9180961
OpenAlexW4281622486

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.